XML 57 R35.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Related Party Transactions (Details Textual) (USD $) | 1 Months Ended | 6 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended |  | 1 Months Ended | 12 Months Ended |  | 1 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Dec. 27, 2012 | Jan. 31, 2012 | Jun. 30, 2013 | Dec. 31, 2011 | Feb. 29, 2012 License, Development and Commercialization Agreement [Member] Note | Jan. 31, 2012 License, Development and Commercialization Agreement [Member] Note | Apr. 30, 2010 Memorial Sloan Kettering Cancer Center [Member] | Dec. 31, 2012 Memorial Sloan Kettering Cancer Center [Member] | Dec. 31, 2011 Memorial Sloan Kettering Cancer Center [Member] | Mar. 27, 2012 Memorial Sloan Kettering Cancer Center [Member] Clinical Trial Agreement [Member] | Jun. 19, 2011 SKI [Member] License, Development and Commercialization Agreement [Member] | Apr. 30, 2010 SKI [Member] License, Development and Commercialization Agreement [Member] | Dec. 31, 2012 SKI [Member] License, Development and Commercialization Agreement [Member] | Dec. 21, 2012 SKI [Member] License, Development and Commercialization Agreement [Member] | Jan. 31, 2012 Dr. Rosemary Mazanet [Member] Consulting Services Agreement [Member] | Dec. 31, 2012 Dr. Rosemary Mazanet [Member] Consulting Services Agreement [Member] | Aug. 07, 2012 Laidlaw and Company [Member] Engagement Agreement [Member] | Dec. 31, 2012 Laidlaw and Company [Member] Engagement Agreement [Member] | May 09, 2011 Jamess Capital Group LLC [Member] Transaction management agreement [Member] | Dec. 31, 2012 Guagenti & Associates LLC [Member]
Related Party Transactions (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of Patients enrolled |  |  |  |  | 2 | 2 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Amount paid under agreement in 2011 |  |  |  |  |  |  |  |  |  |  | $ 50,000 |  |  |  |  |  |  |  |  |
Amount paid under agreement in 2012 |  |  |  |  |  |  |  |  |  |  | 200,000 |  |  |  |  |  |  |  |  |
Amount paid under agreement in 2013 |  |  |  |  |  |  |  |  |  |  | 250,000 |  |  |  |  |  |  |  |  |
Maintenance fees and research payments |  |  |  |  |  |  |  |  |  |  | 50,000 |  |  |  |  |  |  |  |  |
Amount paid under agreement |  |  |  |  |  |  |  |  |  |  |  |  | 100,000 |  |  |  |  |  |  |
Additional amount due under agreement |  |  |  |  |  |  |  |  |  |  |  |  |  | 150,000 |  |  |  |  |  |
Condition for termination of forbearance period |  |  |  |  |  |  |  |  |  |  |  | The forbearance period terminated on October 30, 2011, when the Company satisfied a financing condition to the termination of the forbearance period by raising in excess of $3,000.000 in new equity financing. |  |  |  |  |  |  |  |
Termination date of forbearance agreement |  |  |  |  |  |  | Oct. 30, 2011 |  |  |  |  | Oct. 30, 2011 |  |  |  |  |  |  |  |
Minimum new equity financing needed under condition for termination forbearance period |  |  |  |  |  |  |  |  |  |  |  | 3,000.000 |  |  |  |  |  |  |  |
Forgiven amount of obligations |  |  |  |  |  |  |  |  |  |  |  | 360,000 |  |  |  |  |  |  |  |
Research and development reimbursement payments received from MSKCC |  |  |  |  |  |  |  | 237,834 | 299,200 |  |  |  |  |  |  |  |  |  |  |
Net receivable from MSKCC |  |  |  |  |  |  |  | 0 | 237,834 |  |  |  |  |  |  |  |  |  |  |
Amount paid to each patient after Completing clinical trial |  |  |  |  |  |  |  |  |  | 31,185 |  |  |  |  |  |  |  |  |  |
Start-up fee for clinical trial |  |  |  |  |  |  |  |  |  | 79,623 |  |  |  |  |  |  |  |  |  |
Due date of start-up fee |  |  |  |  |  |  |  |  |  | Jul. 10, 2012 |  |  |  |  |  |  |  |  |  |
Officers' Compensation |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 100,000 |  |  |  |
Option Exercise Price Range |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.78 to 1.5 |  |  |  |  |
Term of options | 6 years | 7 years | 4 years 6 months | 7 years |  |  |  |  |  |  |  |  |  |  | 10 years |  |  |  |  |
Options received to purchase common stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 99,900 |  |  |  |
Description of receivables of placement agent for services |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | Placement agent will receive (a) a cash fee equal to 10% of the gross proceeds raised in the 2012 Common Stock Offering, (b) a non-accountable expense reimbursement equal to 2% of the gross proceeds raised in the 2012 Common Stock Offering, and (c) reimbursement of $100,000 for legal expenses incurred by the placement agent. |  |
Description of warrants receivables by placement |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | The placement agent or its designees have also received warrants to purchase shares of the Company's Common Stock in an amount equal to 10% of the shares of common stock issued as part of the units sold in the 2012 Common Stock Offering and the shares of Common Stock issuable upon exercise of the B warrants included in such units. |  |
Period of exercise of warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | Within 6 months of the final closing of the 2012 common stock Offering. |  |
Percentage of solicitation fee |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 5.00% |  |  |
Monthly fee for financial advisory services |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 25,000 |  |  |
Description of additional receivable by placement agent |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | The agreement also provides that (i) if the Company consummates any merger, acquisition, business combination or other transaction (other than the Share Exchange) with any party introduced to it by the placement agent, the placement agent would receive a fee equal to 10% of the aggregate consideration in such transactions, and (ii) if, within a period of 12 months after termination of the advisory services described above, the Company requires a financing or similar advisory transaction the placement agent will have the right to act as the Company's financial advisor and investment banker in such financing or transaction pursuant to a set fee schedule set forth in the August 7, 2012 engagement agreement. |  |
Warrant held by placement agent to purchase common stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,251,015 |  |  |
Monthly fee received by management firm |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 12,500 |
Percentage of fully diluted capital stock equal to common stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 10.00% |
Maximum amount of out of pocket expenses |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 5,000 |
Operating lease monthly amount of rent |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 300
Amount paid to pursuant lease agreement |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 7,200

X
- Definition Additional amount due under agreement. + References No definition available. + Details
Name: | fil_AdditionalAmountDueUnderAgreement
Namespace Prefix: | fil_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount to be paid for each Patient that has completed the clinical trial. + References No definition available. + Details
Name: | fil_AmountPaidToEachPatient
Namespace Prefix: | fil_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount paid to pursuant lease agreement. + References No definition available. + Details
Name: | fil_AmountPaidToPursuantLeaseAgreement
Namespace Prefix: | fil_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount paid under agreement. + References No definition available. + Details
Name: | fil_AmountPaidUnderAgreement
Namespace Prefix: | fil_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount paid under agreement in year two thousand eleven. + References No definition available. + Details
Name: | fil_AmountPaidUnderAgreementInYearTwoThousandEleven
Namespace Prefix: | fil_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount paid under agreement in year two thousand thirteen. + References No definition available. + Details
Name: | fil_AmountPaidUnderAgreementInYearTwoThousandThirteen
Namespace Prefix: | fil_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount paid under agreement in year two thousand twelve. + References No definition available. + Details
Name: | fil_AmountPaidUnderAgreementInYearTwoThousandTwelve
Namespace Prefix: | fil_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Common stock purchase by holding of warrant. + References No definition available. + Details
Name: | fil_CommonStockPurchaseByHoldingOfWarrant
Namespace Prefix: | fil_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Description of additional receivable by placement agent. + References No definition available. + Details
Name: | fil_DescriptionOfAdditionalReceivableByPlacementAgent
Namespace Prefix: | fil_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Description of condition for termination of forbearance period. + References No definition available. + Details
Name: | fil_DescriptionOfConditionForTerminationOfForbearancePeriod
Namespace Prefix: | fil_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Description of receivables of placement agent for services. + References No definition available. + Details
Name: | fil_DescriptionOfReceivablesOfPlacementAgentForServices
Namespace Prefix: | fil_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Description of warrants receivables by placement. + References No definition available. + Details
Name: | fil_DescriptionOfWarrantsReceivablesByPlacement
Namespace Prefix: | fil_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Forgiven amount of obligations. + References No definition available. + Details
Name: | fil_ForgivenAmountOfObligations
Namespace Prefix: | fil_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Maintenance fees and research payments. + References No definition available. + Details
Name: | fil_MaintenanceFeesAndResearchPayments
Namespace Prefix: | fil_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Maximum amount of out of pocket expenses. + References No definition available. + Details
Name: | fil_MaximumAmountOfOutOfPocketExpenses
Namespace Prefix: | fil_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Minimum new Equity Financing needed under condition for termination Forbearance period. + References No definition available. + Details
Name: | fil_MinimumNewEquityFinancingNeededUnderConditionForTerminationForbearancePeriod
Namespace Prefix: | fil_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Number of patients. + References No definition available. + Details
Name: | fil_NumberOfPatients
Namespace Prefix: | fil_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Option exercise price range. + References No definition available. + Details
Name: | fil_OptionExercisePriceRange
Namespace Prefix: | fil_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Options received to purchase common stock. + References No definition available. + Details
Name: | fil_OptionsReceivedToPurchaseCommonStock
Namespace Prefix: | fil_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of fully diluted capital stock equal to common stock. + References No definition available. + Details
Name: | fil_PercentageOfFullyDilutedCapitalStockEqualToCommonStock
Namespace Prefix: | fil_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of solicitation fee. + References No definition available. + Details
Name: | fil_PercentageOfSolicitationFee
Namespace Prefix: | fil_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Periodic amount of rent. + References No definition available. + Details
Name: | fil_PeriodicAmountOfRent
Namespace Prefix: | fil_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Periodic fee for financial advisory services. + References No definition available. + Details
Name: | fil_PeriodicFeeForFinancialAdvisoryServices
Namespace Prefix: | fil_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Periodic fee received by management firm. + References No definition available. + Details
Name: | fil_PeriodicFeeReceivedByManagementFirm
Namespace Prefix: | fil_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Period of exercise of warrants. + References No definition available. + Details
Name: | fil_PeriodOfExerciseOfWarrants
Namespace Prefix: | fil_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | fil_RelatedPartyTransactionsTextualAbstract
Namespace Prefix: | fil_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Research and development prepayments amount received by related party. + References No definition available. + Details
Name: | fil_ResearchAndDevelopmentPrepaymentsAmountReceivedByRelatedParty
Namespace Prefix: | fil_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Start-up due cost paid date. + References No definition available. + Details
Name: | fil_StartUpDueCostPaidDate
Namespace Prefix: | fil_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | instant

X
- Definition Start-up fee for clinical trial. + References No definition available. + Details
Name: | fil_StartUpFeeForClinicalTrial
Namespace Prefix: | fil_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Termination date of forbearance agreement. + References No definition available. + Details
Name: | fil_TerminationDateOfForbearanceAgreement
Namespace Prefix: | fil_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of receivables arising from transactions with related parties due within one year or the normal operating cycle, if longer. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(k)(1)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 850 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 850 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 850 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 3 -Subparagraph a -Article 5 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph k -Subparagraph 1 -Article 4 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.3(a)(2)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_AccountsReceivableRelatedPartiesCurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Period the instrument, asset or liability is expected to be outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=25499696&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueAssumptionsExpectedTerm
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Expenditures for salaries of officers. Does not include allocated share-based compensation, pension and post-retirement benefit expense or other labor-related non-salary expense. For commercial and industrial companies, excludes any direct and overhead labor that is included in cost of goods sold. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.4) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 + Details
Name: | us-gaap_OfficersCompensation
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration